Výsledky vyhledávání - Lewis Nasr
- Zobrazuji výsledky 1 - 7 z 7
-
1
-
2
Systemic AL amyloidosis: current approach and future direction Autor Maroun Bou Zerdan, Lewis Nasr, Farhan Khalid, Sabine Allam, Youssef Bouferraa, Saba Batool, Muhammad Tayyeb, Shubham Adroja, Mahinbanu Mammadii, Faiz Anwer, Shahzad Raza, Chakra P Chaulagain
Vydáno 2023Revisão -
3
Molecular characterization and predictors of relapse in patients with Ph + ALL after frontline ponatinib and blinatumomab Autor Nicholas J. Short, Hagop Kantarjian, Ken Furudate, Nitin Jain, Farhad Ravandi, Omer Karrar, Sanam Loghavi, Lewis Nasr, Fadi G. Haddad, Jayastu Senapati, Rebecca Garris, Koichi Takahashi, Elias Jabbour
Vydáno 2025Artigo -
4
A phase 1/2 study of mini-hyper-CVD plus venetoclax in patients with relapsed/refractory acute lymphoblastic leukemia Autor Nicholas J. Short, Elias Jabbour, Nitin Jain, Jayastu Senapati, Lewis Nasr, Fadi G. Haddad, Zhenhua Li, Yu-Chih Hsiao, Jun J. Yang, Naveen Pemmaraju, Maro Ohanian, William G. Wierda, Guillermo Montalban‐Bravo, Gautam Borthakur, Lina Han, Lianchun Xiao, Xuelin Huang, Regina Abramova, Min Zhao, Rebecca Garris, Marina Konopleva, Farhad Ravandi, Hagop Kantarjian
Vydáno 2024Artigo -
5
Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALL Autor Yaqi Zhao, Nicholas J. Short, Hagop M. Kantarjian, Ti‐Cheng Chang, Pankaj S. Ghate, Chunxu Qu, Walid Macaron, Nitin Jain, Beenu Thakral, Aaron H. Phillips, Joseph D. Khoury, Guillermo Garcia‐Manero, Wenchao Zhang, Yiping Fan, Hui Yang, Rebecca Garris, Lewis Nasr, Richard W. Kriwacki, Kathryn G. Roberts, Marina Konopleva, Elias Jabbour, Charles G. Mullighan
Vydáno 2024Artigo -
6
Outcomes with bridging radiation therapy prior to chimeric antigen receptor T-cell therapy in patients with aggressive large B-cell lymphomas Autor Gohar Manzar, Chelsea C. Pinnix, Stephanie O. Dudzinski, Kathryn E. Marqueen, E. Elaine, Lewis Nasr, Alison Yoder, Michael K. Rooney, Paolo Strati, Sairah Ahmed, Chijioke Nze, Ranjit Nair, Luis Fayad, Michael Wang, Loretta J. Nastoupil, Jason R. Westin, Christopher R. Flowers, Sattva S. Neelapu, Jillian R. Gunther, Bouthaina S. Dabaja, Susan Wu, Penny Fang
Vydáno 2025Artigo -
7
A phase 1/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agents Autor Nicholas J. Short, Muharrem Müftüoğlu, Faustine Ong, Lewis Nasr, Walid Macaron, Guillermo Montalban‐Bravo, Yesid Alvarado, Mahesh Basyal, Naval Daver, Courtney D. DiNardo, Gautam Borthakur, Nitin Jain, Maro Ohanian, Elias Jabbour, Ghayas C. Issa, Wei Qiao, Xuelin Huang, Rashmi Kanagal‐Shamanna, Keyur P. Patel, Prithviraj Bose, Farhad Ravandi, Ricardo Delumpa, Regina Abramova, Guillermo Garcia‐Manero, Michael Andreeff, Jorge E. Cortés, Hagop M. Kantarjian
Vydáno 2023Artigo
Vyhledávací nástroje:
Související témata
Medicine
Internal medicine
Biology
Immunology
Leukemia
Oncology
Antibody
Biochemistry
Blinatumomab
Cancer research
Cell
Chemotherapy
Chronic lymphocytic leukemia
Gastroenterology
Genetics
Lymphoblastic Leukemia
Receptor
Venetoclax
AL amyloidosis
Acute lymphocytic leukemia
Adverse effect
Amyloidosis
Antigen
Azacitidine
Bone marrow
Bridging (networking)
CD44
Cell adhesion
Cell adhesion molecule
Cell therapy